カテゴリー： LP Information, 世界, 部品/材料

世界の帯状疱疹ワクチン市場予測 2023年-2029年

◆英語タイトル：Global Shingles Vaccine Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23JU3035）◆商品コード：LP23JU3035
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月
◆ページ数：74
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の帯状疱疹ワクチン市場」は、過去の販売実績から2022年の世界の帯状疱疹ワクチンの総販売量を検討し、2023年から2029年の予測される帯状疱疹ワクチンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の帯状疱疹ワクチンの市場規模を掲載し、XXX百万米ドル規模の世界の帯状疱疹ワクチン市場の詳細な分析を提供します。本インサイトレポートは、世界の帯状疱疹ワクチン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の帯状疱疹ワクチン市場における各社の独自のポジションをより深く理解するために、帯状疱疹ワクチン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の帯状疱疹ワクチン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。帯状疱疹ワクチンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。帯状疱疹ワクチンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。帯状疱疹ワクチンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

帯状疱疹ワクチンの世界主要メーカーとしては、Merck、 GlaxoSmithKlineなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の帯状疱疹ワクチン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では帯状疱疹ワクチン市場をセグメンテーションし、種類別 (ゾスタバックス、シングリクス)、用途別 (50歳以下、50～60歳、60～70歳、70歳以上)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：ゾスタバックス、シングリクス

・用途別区分：50歳以下、50～60歳、60～70歳、70歳以上

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の帯状疱疹ワクチン市場の10年間の市場状況・展望は？
・世界および地域別に見た帯状疱疹ワクチン市場成長の要因は何か？
・帯状疱疹ワクチンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・帯状疱疹ワクチンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：帯状疱疹ワクチンの年間販売量2018-2029、地域別現状・将来分析
・帯状疱疹ワクチンの種類別セグメント：ゾスタバックス、シングリクス
・帯状疱疹ワクチンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・帯状疱疹ワクチンの用途別セグメント：50歳以下、50～60歳、60～70歳、70歳以上
・帯状疱疹ワクチンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の帯状疱疹ワクチン市場
・企業別のグローバル帯状疱疹ワクチン市場データ：2018-2023年の年間販売量、市場シェア
・企業別の帯状疱疹ワクチンの年間売上：2018-2023年の売上、市場シェア
・企業別の帯状疱疹ワクチン販売価格
・主要企業の帯状疱疹ワクチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

帯状疱疹ワクチンの地域別レビュー
・地域別の帯状疱疹ワクチン市場規模2018-2023：年間販売量、売上
・主要国別の帯状疱疹ワクチン市場規模2018-2023：年間販売量、売上
・南北アメリカの帯状疱疹ワクチン販売の成長
・アジア太平洋の帯状疱疹ワクチン販売の成長
・ヨーロッパの帯状疱疹ワクチン販売の成長
・中東・アフリカの帯状疱疹ワクチン販売の成長

南北アメリカ市場
・南北アメリカの国別の帯状疱疹ワクチン販売量、売上（2018-2023）
・南北アメリカの帯状疱疹ワクチンの種類別販売量
・南北アメリカの帯状疱疹ワクチンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の帯状疱疹ワクチン販売量、売上（2018-2023）
・アジア太平洋の帯状疱疹ワクチンの種類別販売量
・アジア太平洋の帯状疱疹ワクチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の帯状疱疹ワクチン販売量、売上（2018-2023）
・ヨーロッパの帯状疱疹ワクチンの種類別販売量
・ヨーロッパの帯状疱疹ワクチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の帯状疱疹ワクチン販売量、売上（2018-2023）
・中東・アフリカの帯状疱疹ワクチンの種類別販売量
・中東・アフリカの帯状疱疹ワクチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・帯状疱疹ワクチンの製造コスト構造分析
・帯状疱疹ワクチンの製造プロセス分析
・帯状疱疹ワクチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・帯状疱疹ワクチンの主要なグローバル販売業者
・帯状疱疹ワクチンの主要なグローバル顧客

地域別の帯状疱疹ワクチン市場予測レビュー
・地域別の帯状疱疹ワクチン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・帯状疱疹ワクチンの種類別市場規模予測
・帯状疱疹ワクチンの用途別市場規模予測

主要企業分析
Merck、 GlaxoSmithKline
・企業情報
・帯状疱疹ワクチン製品
・帯状疱疹ワクチン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Shingles Vaccine Industry Forecast” looks at past sales and reviews total world Shingles Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Shingles Vaccine sales for 2023 through 2029. With Shingles Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Shingles Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Shingles Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Shingles Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Shingles Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Shingles Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Shingles Vaccine.
The global Shingles Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Shingles Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Shingles Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Shingles Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Shingles Vaccine players cover Merck and GlaxoSmithKline etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Shingles Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Zostavax
Shingrix
Segmentation by application
Under 50 Years Old
50-60 Years Old
60-70 Years Old
Above 70 Years Old
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Merck
GlaxoSmithKline
Key Questions Addressed in this Report
What is the 10-year outlook for the global Shingles Vaccine market?
What factors are driving Shingles Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Shingles Vaccine market opportunities vary by end market size?
How does Shingles Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Shingles Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Shingles Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Shingles Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Shingles Vaccine Segment by Type
2.2.1 Zostavax
2.2.2 Shingrix
2.3 Shingles Vaccine Sales by Type
2.3.1 Global Shingles Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Shingles Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Shingles Vaccine Sale Price by Type (2018-2023)
2.4 Shingles Vaccine Segment by Application
2.4.1 Under 50 Years Old
2.4.2 50-60 Years Old
2.4.3 60-70 Years Old
2.4.4 Above 70 Years Old
2.5 Shingles Vaccine Sales by Application
2.5.1 Global Shingles Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Shingles Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Shingles Vaccine Sale Price by Application (2018-2023)
3 Global Shingles Vaccine by Company
3.1 Global Shingles Vaccine Breakdown Data by Company
3.1.1 Global Shingles Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Shingles Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Shingles Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Shingles Vaccine Revenue by Company (2018-2023)
3.2.2 Global Shingles Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Shingles Vaccine Sale Price by Company
3.4 Key Manufacturers Shingles Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Shingles Vaccine Product Location Distribution
3.4.2 Players Shingles Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Shingles Vaccine by Geographic Region
4.1 World Historic Shingles Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Shingles Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Shingles Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Shingles Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Shingles Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Shingles Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Shingles Vaccine Sales Growth
4.4 APAC Shingles Vaccine Sales Growth
4.5 Europe Shingles Vaccine Sales Growth
4.6 Middle East & Africa Shingles Vaccine Sales Growth
5 Americas
5.1 Americas Shingles Vaccine Sales by Country
5.1.1 Americas Shingles Vaccine Sales by Country (2018-2023)
5.1.2 Americas Shingles Vaccine Revenue by Country (2018-2023)
5.2 Americas Shingles Vaccine Sales by Type
5.3 Americas Shingles Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Shingles Vaccine Sales by Region
6.1.1 APAC Shingles Vaccine Sales by Region (2018-2023)
6.1.2 APAC Shingles Vaccine Revenue by Region (2018-2023)
6.2 APAC Shingles Vaccine Sales by Type
6.3 APAC Shingles Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Shingles Vaccine by Country
7.1.1 Europe Shingles Vaccine Sales by Country (2018-2023)
7.1.2 Europe Shingles Vaccine Revenue by Country (2018-2023)
7.2 Europe Shingles Vaccine Sales by Type
7.3 Europe Shingles Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Shingles Vaccine by Country
8.1.1 Middle East & Africa Shingles Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Shingles Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Shingles Vaccine Sales by Type
8.3 Middle East & Africa Shingles Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Shingles Vaccine
10.3 Manufacturing Process Analysis of Shingles Vaccine
10.4 Industry Chain Structure of Shingles Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Shingles Vaccine Distributors
11.3 Shingles Vaccine Customer
12 World Forecast Review for Shingles Vaccine by Geographic Region
12.1 Global Shingles Vaccine Market Size Forecast by Region
12.1.1 Global Shingles Vaccine Forecast by Region (2024-2029)
12.1.2 Global Shingles Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Shingles Vaccine Forecast by Type
12.7 Global Shingles Vaccine Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Shingles Vaccine Product Portfolios and Specifications
13.1.3 Merck Shingles Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Shingles Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Shingles Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Zostavax
Table 4. Major Players of Shingrix
Table 5. Global Shingles Vaccine Sales by Type (2018-2023) & (K Doses)
Table 6. Global Shingles Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Shingles Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Shingles Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Shingles Vaccine Sale Price by Type (2018-2023) & (USD/Dose)
Table 10. Global Shingles Vaccine Sales by Application (2018-2023) & (K Doses)
Table 11. Global Shingles Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Shingles Vaccine Revenue by Application (2018-2023)
Table 13. Global Shingles Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Shingles Vaccine Sale Price by Application (2018-2023) & (USD/Dose)
Table 15. Global Shingles Vaccine Sales by Company (2018-2023) & (K Doses)
Table 16. Global Shingles Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Shingles Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Shingles Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Shingles Vaccine Sale Price by Company (2018-2023) & (USD/Dose)
Table 20. Key Manufacturers Shingles Vaccine Producing Area Distribution and Sales Area
Table 21. Players Shingles Vaccine Products Offered
Table 22. Shingles Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Shingles Vaccine Sales by Geographic Region (2018-2023) & (K Doses)
Table 26. Global Shingles Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Shingles Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Shingles Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Shingles Vaccine Sales by Country/Region (2018-2023) & (K Doses)
Table 30. Global Shingles Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Shingles Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Shingles Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Shingles Vaccine Sales by Country (2018-2023) & (K Doses)
Table 34. Americas Shingles Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Shingles Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Shingles Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Shingles Vaccine Sales by Type (2018-2023) & (K Doses)
Table 38. Americas Shingles Vaccine Sales by Application (2018-2023) & (K Doses)
Table 39. APAC Shingles Vaccine Sales by Region (2018-2023) & (K Doses)
Table 40. APAC Shingles Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Shingles Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Shingles Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Shingles Vaccine Sales by Type (2018-2023) & (K Doses)
Table 44. APAC Shingles Vaccine Sales by Application (2018-2023) & (K Doses)
Table 45. Europe Shingles Vaccine Sales by Country (2018-2023) & (K Doses)
Table 46. Europe Shingles Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Shingles Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Shingles Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Shingles Vaccine Sales by Type (2018-2023) & (K Doses)
Table 50. Europe Shingles Vaccine Sales by Application (2018-2023) & (K Doses)
Table 51. Middle East & Africa Shingles Vaccine Sales by Country (2018-2023) & (K Doses)
Table 52. Middle East & Africa Shingles Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Shingles Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Shingles Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Shingles Vaccine Sales by Type (2018-2023) & (K Doses)
Table 56. Middle East & Africa Shingles Vaccine Sales by Application (2018-2023) & (K Doses)
Table 57. Key Market Drivers & Growth Opportunities of Shingles Vaccine
Table 58. Key Market Challenges & Risks of Shingles Vaccine
Table 59. Key Industry Trends of Shingles Vaccine
Table 60. Shingles Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Shingles Vaccine Distributors List
Table 63. Shingles Vaccine Customer List
Table 64. Global Shingles Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 65. Global Shingles Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Shingles Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 67. Americas Shingles Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Shingles Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 69. APAC Shingles Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Shingles Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 71. Europe Shingles Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Shingles Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Middle East & Africa Shingles Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Shingles Vaccine Sales Forecast by Type (2024-2029) & (K Doses)
Table 75. Global Shingles Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Shingles Vaccine Sales Forecast by Application (2024-2029) & (K Doses)
Table 77. Global Shingles Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Shingles Vaccine Product Portfolios and Specifications
Table 80. Merck Shingles Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. GlaxoSmithKline Basic Information, Shingles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. GlaxoSmithKline Shingles Vaccine Product Portfolios and Specifications
Table 85. GlaxoSmithKline Shingles Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 86. GlaxoSmithKline Main Business
Table 87. GlaxoSmithKline Latest Developments
List of Figures
Figure 1. Picture of Shingles Vaccine
Figure 2. Shingles Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Shingles Vaccine Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Shingles Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Shingles Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Zostavax
Figure 10. Product Picture of Shingrix
Figure 11. Global Shingles Vaccine Sales Market Share by Type in 2022
Figure 12. Global Shingles Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Shingles Vaccine Consumed in Under 50 Years Old
Figure 14. Global Shingles Vaccine Market: Under 50 Years Old (2018-2023) & (K Doses)
Figure 15. Shingles Vaccine Consumed in 50-60 Years Old
Figure 16. Global Shingles Vaccine Market: 50-60 Years Old (2018-2023) & (K Doses)
Figure 17. Shingles Vaccine Consumed in 60-70 Years Old
Figure 18. Global Shingles Vaccine Market: 60-70 Years Old (2018-2023) & (K Doses)
Figure 19. Shingles Vaccine Consumed in Above 70 Years Old
Figure 20. Global Shingles Vaccine Market: Above 70 Years Old (2018-2023) & (K Doses)
Figure 21. Global Shingles Vaccine Sales Market Share by Application (2022)
Figure 22. Global Shingles Vaccine Revenue Market Share by Application in 2022
Figure 23. Shingles Vaccine Sales Market by Company in 2022 (K Doses)
Figure 24. Global Shingles Vaccine Sales Market Share by Company in 2022
Figure 25. Shingles Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Shingles Vaccine Revenue Market Share by Company in 2022
Figure 27. Global Shingles Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Shingles Vaccine Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Shingles Vaccine Sales 2018-2023 (K Doses)
Figure 30. Americas Shingles Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. APAC Shingles Vaccine Sales 2018-2023 (K Doses)
Figure 32. APAC Shingles Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Europe Shingles Vaccine Sales 2018-2023 (K Doses)
Figure 34. Europe Shingles Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Shingles Vaccine Sales 2018-2023 (K Doses)
Figure 36. Middle East & Africa Shingles Vaccine Revenue 2018-2023 ($ Millions)
Figure 37. Americas Shingles Vaccine Sales Market Share by Country in 2022
Figure 38. Americas Shingles Vaccine Revenue Market Share by Country in 2022
Figure 39. Americas Shingles Vaccine Sales Market Share by Type (2018-2023)
Figure 40. Americas Shingles Vaccine Sales Market Share by Application (2018-2023)
Figure 41. United States Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Shingles Vaccine Sales Market Share by Region in 2022
Figure 46. APAC Shingles Vaccine Revenue Market Share by Regions in 2022
Figure 47. APAC Shingles Vaccine Sales Market Share by Type (2018-2023)
Figure 48. APAC Shingles Vaccine Sales Market Share by Application (2018-2023)
Figure 49. China Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Shingles Vaccine Sales Market Share by Country in 2022
Figure 57. Europe Shingles Vaccine Revenue Market Share by Country in 2022
Figure 58. Europe Shingles Vaccine Sales Market Share by Type (2018-2023)
Figure 59. Europe Shingles Vaccine Sales Market Share by Application (2018-2023)
Figure 60. Germany Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Shingles Vaccine Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Shingles Vaccine Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Shingles Vaccine Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Shingles Vaccine Sales Market Share by Application (2018-2023)
Figure 69. Egypt Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Shingles Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Shingles Vaccine in 2022
Figure 75. Manufacturing Process Analysis of Shingles Vaccine
Figure 76. Industry Chain Structure of Shingles Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Shingles Vaccine Sales Market Forecast by Region (2024-2029)
Figure 79. Global Shingles Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Shingles Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Shingles Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Shingles Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Shingles Vaccine Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の帯状疱疹ワクチン市場予測 2023年-2029年(Global Shingles Vaccine Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ファイバーグラスシングルの世界市場見通し2023年-2029年
  • 世界の鼻腔内治療薬＆ワクチン送達装置市場予測 2023年-2029年
  • アスファルトシングルの世界市場見通し2023年-2029年
  • 世界のワクチン保管における医療用冷蔵庫市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆